#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4147209	Functional	Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	26	ALA4145492	organism-based format	Scientific Literature
2.	ALA4147210	Functional	Antiviral activity against HIV2 ROD infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 2	22	ALA4145492	organism-based format	Scientific Literature
3.	ALA4147211	ADME	Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 4 days by MTT assay	Homo sapiens	26	ALA4145492	cell-based format	Scientific Literature
4.	ALA4147212	Toxicity	Selectivity index, ratio of CC50 for human MT4 cells to EC50 for wild type HIV1 3B		26	ALA4145492	assay format	Scientific Literature
5.	ALA4147213	Functional	Antiviral activity against HIV1 harboring reverse transcriptase L100I mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
6.	ALA4147214	Functional	Antiviral activity against HIV1 harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
7.	ALA4147215	Functional	Antiviral activity against HIV1 harboring reverse transcriptase Y181C mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
8.	ALA4147216	Functional	Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
9.	ALA4147217	Functional	Antiviral activity against HIV1 harboring reverse transcriptase E138K mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
10.	ALA4147218	Functional	Antiviral activity against HIV1 RES056 harboring reverse transcriptase K103 N/Y181C double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
11.	ALA4147219	Functional	Antiviral activity against HIV1 harboring reverse transcriptase F227L/V106A double mutant infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 4 days by MTT assay	Human immunodeficiency virus 1	8	ALA4145492	organism-based format	Scientific Literature
12.	ALA4147220	Binding	Inhibition of recombinant wild type HIV1 reverse transcriptase p66/p51 using poly (rA)/anoligo (dT)16 as template/primer assessed as inhibition of biotin-dUTP incorporation after 40 mins by Pico-Green staining based fluorescence assay	Human immunodeficiency virus 1	24	ALA4145492	single protein format	Scientific Literature